ResMed (RMD) Insider Trading & Ownership $228.61 -1.65 (-0.72%) As of 01/14/2025 03:58 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ResMed (NYSE:RMD) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.71%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$42.61 M Get RMD Insider Trade Alerts Want to know when executives and insiders are buying or selling ResMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address RMD Insider Buying and Selling by Quarter ResMed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/4/2024Peter C FarrellDirectorSell2,000$245.65$491,300.00 12/2/2024Michael J RiderGeneral CounselSell74$248.91$18,419.34 11/22/2024Justin LeongInsiderSell6,160$243.09$1,497,434.40 11/12/2024Witte Jan DeDirectorSell796$248.81$198,052.76 11/6/2024Peter C FarrellDirectorSell2,000$248.74$497,480.00 11/1/2024Michael J RiderGeneral CounselSell69$242.00$16,698.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 10/11/2024Kaushik GhoshalInsiderSell4,260$238.48$1,015,924.80 10/8/2024Brett SandercockCFOSell1,000$233.47$233,470.00 10/7/2024Michael J FarrellCEOSell14,683$231.91$3,405,134.53 10/7/2024Michael J FarrellCEOSell14,683$231.91$3,405,134.53 10/2/2024Peter C FarrellDirectorSell2,000$237.20$474,400.00 9/12/2024Kaushik GhoshalInsiderSell5,000$252.56$1,262,800.00 9/9/2024Brett SandercockCFOSell1,000$246.42$246,420.00 9/9/2024Michael J FarrellCEOSell14,683$248.38$3,646,963.54 9/4/2024Peter C FarrellDirectorSell2,000$239.90$479,800.00 8/20/2024Michael J RiderGeneral CounselSell882$231.00$203,742.00 8/8/2024Brett SandercockCFOSell1,000$212.16$212,160.00 8/7/2024Michael J FarrellCEOSell14,683$214.25$3,145,832.75 8/5/2024Justin LeongInsiderSell48,000$217.07$10,419,360.00 7/8/2024Brett SandercockCFOSell1,000$194.35$194,350.00 7/8/2024Michael J FarrellCEOSell14,683$192.97$2,833,378.51 6/10/2024Brett SandercockCFOSell1,000$209.81$209,810.00 6/7/2024Michael J FarrellCEOSell14,683$211.66$3,107,803.78 5/15/2024Witte Jan DeDirectorSell360$218.29$78,584.40 5/7/2024Michael J FarrellCEOSell14,683$216.50$3,178,869.50 5/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$216.98$1,001 - $15,0004/29/2024Karen DrexlerDirectorSell425$214.92$91,341.00 3/4/2024Michael J RiderGeneral CounselSell81$180.00$14,580.00 3/1/2024Michael J RiderGeneral CounselSell200$173.25$34,650.00 2/22/2024Peter C FarrellDirectorSell10,935$182.66$1,997,387.10 (Data available from 1/1/2013 forward) RMD Insider Trading Activity - Frequently Asked Questions Who is on ResMed's Insider Roster? The list of insiders at ResMed includes Brett Sandercock, David Pendarvis, Justin Leong, Karen Drexler, Kaushik Ghoshal, Lucile Blaise, Michael J Farrell, Michael J Rider, Peter C Farrell, Robert Andrew Douglas, and Witte Jan De. Learn more on insiders at RMD. What percentage of ResMed stock is owned by insiders? 0.71% of ResMed stock is owned by insiders. Learn more on RMD's insider holdings. Which ResMed insiders have been selling company stock? The following insiders have sold RMD shares in the last 24 months: Brett Sandercock ($3,209,073.30), David Pendarvis ($1,675,275.00), Justin Leong ($11,916,794.40), Karen Drexler ($225,929.52), Kaushik Ghoshal ($3,078,374.80), Michael J Farrell ($35,000,981.76), Michael J Rider ($306,356.09), Peter C Farrell ($3,940,367.10), Robert Andrew Douglas ($2,575,605.00), and Witte Jan De ($276,637.16). How much insider selling is happening at ResMed? Insiders have sold a total of 289,571 ResMed shares in the last 24 months for a total of $62,205,394.13 sold. Which members of congress are trading ResMed? Tommy Tuberville (R-AL) has sold shares of ResMed in the last year totaling $8,000. ResMed Key ExecutivesMr. Michael J. Farrell BE (Age 52)MBA, SM, CEO & Chairman Compensation: $2.92M4 recent tradesDr. Peter C. Farrell A.M. (Age 82)B.E., BE (Hons), Ph.D., ScD, Founder, Chair Emeritus & Director Compensation: $459.72kMr. Brett A. Sandercock (Age 57)Chief Financial Officer Compensation: $933.66k3 recent tradesMr. Michael J. Rider (Age 66)Chief Legal Officer & Secretary Compensation: $854.32k3 recent tradesMr. Justin Leong (Age 47)Chief Product Officer Compensation: $1.2M2 recent tradesMr. Kaushik Ghoshal (Age 56)Chief Commercial Officer - SaaS Compensation: $1.23M2 recent tradesMr. Alastair RobertsonChief Information OfficerMs. Amy WakehamChief Investor Relations OfficerMr. Jim EllisChief Compliance OfficerMs. Yvonne-Katrin PucknatChief Marketing Officer More Insider Trading Tools from MarketBeat Related Companies Medtronic Insider Trading Becton, Dickinson and Company Insider Trading Edwards Lifesciences Insider Trading IDEXX Laboratories Insider Trading DexCom Insider Trading STERIS Insider Trading Insulet Insider Trading Hologic Insider Trading Baxter International Insider Trading Globus Medical Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Zymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop BuyingAppLovin Insiders Sell Shares: Stock Price Indicated Higher This page (NYSE:RMD) was last updated on 1/15/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowAll of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ResMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ResMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
